This week was quiet on the trading front - no new buys or sells.
Discover the top-performing stocks of the week with our Momentum Ranking! Click here to access the latest data for week 35.
This Week’s Trading Update: Staying Cautious
In this week’s trading activity, we continue to navigate the market with a careful approach, guided by Andreas Clenow’s strategies detailed in “Stocks On The Move.” As of today, the S&P 500 has been above its 200-day moving average for 205 days, enabling us to consider new positions if the opportunities align.
Buys/Sells
This week, there were no new buys, sells, or rebalances. Our portfolio remains stable, with a significant portion held in cash reserves. This cautious stance reflects our systematic trading strategy, which requires stocks to meet stringent criteria before being added to our holdings.
Summary
Our portfolio is well diversified, primarily in cash and a few key holdings like Halozyme Therapeutics, Inc. (HALO) and Corcept Therapeutics Incorporated (CORT). Over the last seven trading days, Lantheus Holdings Inc. (LNTH) emerged as our top performer, delivering a gain of 13.07%. On the downside, cash showed no movement with a stable position.
Focusing on long-term momentum and maintaining discipline, we prioritize adjusting our holdings based on performance and market conditions. With the S&P 500 above its 200-day moving average, we are poised but selective with potential new buys.
In conclusion, this week’s performance aligns with our long-term momentum ranking strategy. We encourage you to share your thoughts and questions in the comments below. Stay tuned for future updates as we continuously adapt to the market dynamics. Investing is a journey, and we’re here to navigate it together.

This week’s transactions:
-
Sold:
- No sells in this week!
-
Bought:
- No buys in this week!
-
Rebalanced / added:
- No positions were added to in this week!
-
Rebalanced / reduced:
- No positions were reduced in this week!
Index Distribution:
At the moment, we are holding mostly cash:
Current portfolio allocation:
Things are a bit quiet in the portfolio, mostly just cash and waiting for the right moment:
Weekly sector distribution:
Current portfolio (@finviz):
| Symbol | Name | Index | Sector | MC | Dist to 52w High | pct |
|---|---|---|---|---|---|---|
| cash | Cash | Cash | Cash | – | 167456 | 0.915 |
| HALO | Halozyme Therapeutics Inc. | S&P 400 | Healthcare | 8.02B | -0.12% | 0.014 |
| CORT | Corcept Therapeutics Inc | Barrons 400 | Healthcare | 3.65B | -12.09% | 0.014 |
| UTHR | United Therapeutics Corp | S&P 400 | Healthcare | 15.51B | -1.40% | 0.013 |
| CRUS | Cirrus Logic, Inc. | S&P 400 | Technology | 7.65B | -1.32% | 0.011 |
| LMB | Limbach Holdings Inc | Barrons 400 | Industrials | 734.69M | -2.18% | 0.011 |
| TPL | Texas Pacific Land Corporation | S&P 400 | Energy | 19.65B | -1.77% | 0.009 |
| TBBK | Bancorp Inc. | Barrons 400 | Financial Services | 2.47B | -5.74% | 0.008 |
| LNTH | Lantheus Holdings Inc | S&P 400 | Healthcare | 7.56B | -14.22% | 0.006 |
As always, more trades next week!